¿Quieres mejorar el contenido de la página? Propón un cambio.
Progress Reports
TATFAR 2021 Progress Report summarizing work from 2016-2020 to address the growing global threat of...
Apr. 24, 2024 Download
TATFAR 2014 Progress Report with recommendations for future collaboration between the US and EU.
Feb. 19, 2024 Download
Through regular meetings and several public consultations, the members of the TATFAR have identified...
Apr. 24, 2024 Download
Publications
TATFAR Reporting of sales and use of antimicrobials per animal species
The aim of this paper is to present the different approaches taken by TATFAR member countries, highl...
Apr. 24, 2024 Download
2019 Targets for the reduction of antibiotic use in humans
2017 Pull incentives for antibacterial drug development
2016 Economic incentives for antimicrobial therapy development
Report on the modified Delphi process for common structure and process indicators for hospital antim...
Feb. 19, 2024 Download
Using Available Data Sources Track Antibiotic Use
Using available data sources at the country level to track antibiotic use.
Feb. 20, 2024 Download
Video clips
2018 TATFAR March 7-8 Meeting Opening Session
Historical Documents
Report on the Joint EU-US Workshop
Apr. 24, 2024 Download
Canada
Tackling Antimicrobial Resistance and Antimicrobial Use: A Pan-Canadian Framework for Action
European Union
A European One Health Action Plan against Antimicrobial Resistance (AMR)
Norway
Norway: Norwegian National Strategy Against Antibiotic Resistance 2015-2020
United States
About Antimicrobial Resistance Investments & Action
CDC’s Antimicrobial Resistance Solutions Initiative invests in national infrastructure to detect, re...
Fiscal Year 2021: U.S. National Action Plan Progress Report (published in 2023)
Year 5: U.S. National Action Plan Progress Report (published in 2022)
Year 4: U.S. National Action Plan Progress Report (published in 2020)
Year 3: U.S. National Action Plan Progress Report (published 2018)
Year 1 and 2: U.S. National Action Plan Progress Report (published 2017)
Centers for Disease Control and Prevention
Antimicrobial Resistance Threats in the United States, 2021-2022
CDC used new data to update the U.S. burden of seven antimicrobial-resistant pathogens.
Antibiotic Use and Stewardship in the United States, 2024 Update: Progress and Opportunities
The report provides an overview of the current state of antibiotic use and stewardship in human heal...
Initiatives for Addressing Antimicrobial Resistance in the Environment are two corresponding reports published in 2018 an overview of the current evidence base and ongoing knowledge gaps around antibiotic resistance in the environment (e.g. water, soil) and the potential effect on human health.
Current Situation and Challenges (2018)
European Centre for Disease Prevention and Control
Will COVID-19 have an impact on AMR?
Antimicrobial Resistance in Europe, ECDC, 2011
The Bacterial Challenge: Time to React, ECDC, 2009
European Commission
Research, Innovation, and Policy: An Alliance Combating AMR, 2019
A European One Heath Action Plan against Antimicrobial Resistance, 2017
Progress report on the Action plan against the rising threats from Antimicrobial Resistance, 2015
Action plan against rising threats from Antimicrobial Resistance, 2011
European Food Safety Authority
European Medicines Agency
Public Health Agency of Canada
Canadian Antimicrobial Resistance Surveillance System - Update 2020
U.S. Food and Drug Administration
U.S. National Institute of Allergy and Infectious Diseases
NIAID’S Antibiotic Resistance Research Framework: Current Status and Future Directions, 2019
Antimicrobial Resistance Funding
Find funding opportunities related to AMR on the agency or organization website or reach out to a contact listed for more information.
| Organization | Contact | Funding Opportunities |
|---|---|---|
| Biomedical Advanced Research and Development Authority (BARDA) | Mark Albrecht, Mark.Albrecht@hhs.gov | BARDA: Check for Project BioShield Broad Agency Announcement for Antimicrobials |
| Canadian Institutes of Health Research | Edith Brochu, edith.brochu@cihr-irsc.gc.ca | Funding for AMR Research |
| CARB-X | CARB-X Funding & Support | |
| CDC | Rachael Aubert, vrl7@cdc.gov | AMR Funding Announcements |
| Directorate-General for Research and Innovation | Arjon van Hengel, Adrianus.Van-Hengel@ec.europa.eu | Research & Innovation Opportunities Horizon Europe European & Developing Countries Clinical Trial Partnership |
| Innovative Medicines Initiative | Open calls | |
| Joint Programming Initiative on AMR | Edith Brochu, edith.brochu@cihr-irsc.gc.ca | JPIAMR One Health Intervention |
| National Institute of Health | Dennis Dixon dmdixon@niaid.nih.gov | AMR Research Initiatives Funding Opportunity Announcements (FOA) & Notices of Special Interest (NOSI) Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB) |
| Norwegian Institute of Public Health | Christine Årdal, christine.ardal@fhi.no | Call for Proposals, including AMR Related Opportunities |
| U.S. Department of Agriculture | Kathe Bjork, kathe.e.bjork@usda.gov | USDA AMR One Health & AMR |
January 31, 2025
Where this page came from
This page was imported from Centers for Disease Control and Prevention. Material produced by the Centers for Disease Control and Prevention is a work of the United States government and is in the public domain.
Nobody has written it yet — it is the source material at a new address, which is why search engines are asked to skip it and why no one earns from it. It is up for grabs: take it on, and it is yours to rewrite and to earn from.
Licencia: CC0 1.0 (dominio público) · Adaptado de www.cdc.gov
1
0
0
0

Comentarios

Sigue leyendo





